The Eye Health Group is a leading vision support organization that assists its nine New Jersey and New York practice providers in performing comprehensive eyecare services. The Eye Health Group provides a full suite of medical eyecare services, from diagnosis and management of eye diseases to pathology, lab testing and pre- and post-operative care for surgical patients, as well as prescribing and dispensing contact lenses and vision corrective glasses. The Eye Health Group’s management team will remain involved in the operations of the business.
“At Beverly Capital, we focus on bringing growth capital and operational excellence to the companies in which we invest,” said Daniel Rudyak, Managing Director, Beverly Capital. “We see an opportunity to build upon this platform investment with additional acquisitions of eye health practices along the East Coast. We look forward to working with The Eye Health Group to help it scale, innovate and continue to succeed in the years ahead.”
Beverly Capital was joined in the investment by Everside Capital Partners, a New York-based investment firm, and Merion Investment Partners, a Pennsylvania-based investment firm.
“The Covid pandemic has accelerated change in the optometry sector. A patient-centric model, robust medical offerings, and large regional footprint will be needed to thrive in the future,” said Dr. Randy Nissinoff, CEO, The Eye Health Group. “We are proud of the tremendous care and compassion provided by the significantly growing number of optometric doctors that The Eye Health Group supports, and are excited about our new partnership with Beverly Capital, providing us an ability to expedite our growth across the Northeast.”